Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuropsychiatric lupus.

John G Hanly1

  • 1Division of Rheumatology, Arthritis Center of Nova Scotia, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS B3H 4K4, Canada. john.hanly@cdha.nshealth.ca

Rheumatic Diseases Clinics of North America
|June 1, 2005
PubMed
Summary

Systemic lupus erythematosus (SLE) can cause diverse nervous system diseases, including neurologic and psychiatric issues. Diagnosis and treatment for these conditions are complex due to a lack of gold standards and controlled studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohort.

Lupus science & medicine·2026
Same author

Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.

Journal of clinical epidemiology·2026
Same author

Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.

Annals of the rheumatic diseases·2025
Same author

Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Towards a minimal core dataset for systemic lupus erythematosus studies.

Lupus science & medicine·2025
Same author

An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial.

Rheumatology (Oxford, England)·2025

Area of Science:

  • Rheumatology and Neurology
  • Immunology and Neuroscience

Background:

  • Systemic lupus erythematosus (SLE) frequently impacts the nervous system, presenting a wide array of neurologic and psychiatric symptoms.
  • These nervous system complications in SLE can arise from the disease itself, its treatments, or unrelated conditions.
  • The underlying causes are multifactorial, involving vascular damage, autoantibodies, and neuroinflammation.

Purpose of the Study:

  • To explore the spectrum of nervous system manifestations in patients with SLE.
  • To discuss the diagnostic challenges and therapeutic strategies for neuropsychiatric (NP) SLE.

Main Methods:

  • Review of existing literature on NP manifestations in SLE.
  • Discussion of diagnostic investigations used to support clinical diagnosis and assess disease severity.
  • Analysis of current, largely empiric, treatment approaches.

Main Results:

  • NP manifestations in SLE are diverse, encompassing both neurological and psychiatric features.
  • Etiologies include intracranial vascular injury, autoantibodies, and cytokine generation.
  • Diagnostic gold standards are often lacking, necessitating a range of investigations.

Conclusions:

  • Diagnosing NP-SLE requires a comprehensive approach due to the absence of definitive diagnostic markers.
  • Treatment strategies are primarily empiric, focusing on immunosuppression, symptom management, and addressing non-SLE factors.
  • Further controlled studies are needed to establish evidence-based treatment guidelines.

Related Experiment Videos